GR Dos Passos, LM Oliveira, BK Da Costa… - Frontiers in …, 2018 - frontiersin.org
Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been found in some cases diagnosed as seronegative neuromyelitis optica spectrum disorder (NMOSD) …
Clinical trial results of peripheral B cell depletion indicate abnormal proinflammatory B cell properties, and particularly antibody-independent functions, contribute to relapsing MS …
A Bruscolini, M Sacchetti, M La Cava, M Gharbiya… - Autoimmunity …, 2018 - Elsevier
Neuromyelitis optica (NMO) and Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune conditions characterized by inflammatory involvement of the optic …
Background Myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) associated disorder (MOGAD) is a CNS demyelinating disease distinct from neuromyelitis optica …
S Carta, D Ferraro, S Ferrari, C Briani… - Critical reviews in …, 2022 - Taylor & Francis
Oligoclonal immunoglobulin G (IgG) bands (OCBs) are a useful diagnostic tool to detect a central humoral response. In particular, cerebrospinal fluid (CSF)-restricted OCBs represent …
M Jasiak-Zatonska, A Kalinowska-Lyszczarz… - International journal of …, 2016 - mdpi.com
Neuromyelitis optica (NMO) is an autoimmune, demyelinating disorder of the central nervous system (CNS) with typical clinical manifestations of optic neuritis and acute …
P Schindler, O Aktas, M Ringelstein… - Expert Review of …, 2023 - Taylor & Francis
Introduction Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, often debilitating neuroinflammatory disease, whose predominant clinical manifestations are …
Neuromyelitis optica spectrum disorders (NMOSD) are mostly relapsing inflammatory disorders of the central nervous system (CNS). Optic neuritis (ON) is the first NMOSD-related …